Section Arrow
Quote
TIVC.NASDAQ
- Tivic Health Systems Inc
(Financial Status)
Quotes are at least 15-min delayed:2026/04/25 21:19 EDT
Regular Hours
Last
 1.33
+0.21 (+18.75%)
Day High 
1.35 
Prev. Close
1.12 
1-M High
1.29 
Volume 
1.24M 
Bid
1.28
Ask
1.32
Day Low
1.18 
Open
1.35 
1-M Low
0.8226 
Market Cap 
3.22M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.08 
20-SMA 1.02 
50-SMA 0.93 
52-W High 6.95 
52-W Low 0.721683 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-7.84/-24.00
Enterprise Value
9.68M
Balance Sheet
Book Value Per Share
5.84
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.49
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ITOCiTonic Holdings Ltd.0.374+0.0744+24.83%-- 
BSXBoston Scientific Corp62.07-3.62-5.51%33.94PE
ABTAbbott Laboratories91.13-1.35-1.46%24.75PE
EWEdwards Lifesciences Corp84.15+4.43+5.56%45.45PE
PACBPacific Biosciences of California1.56-0.01-0.64%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Tivic Health Systems Inc is a late-stage biopharmaceutical company focused on the development of biologics, with its lead product candidate, Entolimod, a TLR5 agonist, being developed for acute radiation syndrome and oncology-related indications. The company operates through two segments: a biopharma segment focused on product development and commercialization, and a contract development and manufacturing organization (CDMO) segment providing manufacturing and development services through its subsidiary.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.